Rapid tests
Respiratory rapid tests for influenza A and B
The ATFirst™ Flu A & B lateral flow test for nasal and nasopharyngeal specimens, for professional use outside the United States.
- Professional use
- Lateral flow format
- 1 product
Respiratory rapid tests for clinics and laboratories
First Diagnostic™ Corporation supplies respiratory rapid tests for professional in vitro diagnostic use. The range centers on one product, the ATFirst™ Flu A & B test, which detects influenza A and B nucleoprotein antigens and distinguishes type A from type B.
Lateral flow tests of this kind are used in outpatient and emergency departments, primary care clinics and hospital laboratories during the influenza season. Each result is an aid to diagnosis and must be interpreted by a clinician with other clinical and laboratory findings.
Products in this range
| Product | Detects | Specimen | Time to result | Catalog / REF |
|---|---|---|---|---|
| ATFirst™ Flu A & B | Influenza A and B nucleoprotein antigens | Nasal swab, nasopharyngeal swab, nasopharyngeal aspirate/wash | 10–15 min (negatives at 15) | 85226400110 |
Specimens and read time are taken from the ATFirst™ Flu A & B sample laboratory procedure. The instructions supplied with the kit are the governing document.
Choose by need
Antigen test for nasal swabs, nasopharyngeal swabs and nasopharyngeal aspirate or wash. 20 tests per kit (see kit label).
These tests have no product page and are supplied on request.
Also available on request
Strep A, RSV and mononucleosis (catalog 85226400095) rapid tests are available on request. Contact us with the quantity and destination country to check availability.
Using influenza antigen results responsibly
- A negative result does not exclude infection with influenza A or B; results are used together with clinical findings.
- The test distinguishes influenza A from B but does not identify subtypes or strains.
- It detects both viable and non-viable virus, and its performance has not been established for monitoring antiviral treatment.
- Predictive values depend on how much influenza is circulating.
- A nasally administered influenza A vaccine may produce a positive result for up to three days after vaccination.
Frequently asked questions
What documentation comes with this test?
Each kit includes its instructions for use. A sample laboratory procedure for ATFirst™ Flu A & B can be downloaded from the product inserts page.
What regulatory documentation is available for this range?
Regulatory documentation is available on request. Regulatory status varies by country, so name the destination market when you ask.
Is there a minimum order, and how do I get a quote?
Minimum order quantities and prices are confirmed in each quotation. Send the products, quantities and destination country through the contact page.
What is the shelf life?
The expiry date is printed on each kit; ask for current lot dating when you request a quote.
Related
- STI rapid tests — Chlamydia, gonorrhea, syphilis and HSV
- Hepatitis and HIV rapid tests — HBsAg, HCV, HIV and combo tests
- Malaria and dengue rapid tests — Malaria P.f. and dengue IgG/IgM
- ToRCH and prenatal rapid tests — Rubella, CMV, HSV and ToRCH IgM
- Cardiac marker and CRP rapid tests — Troponin I, myoglobin, combo and CRP
- Tumor-marker, H. pylori and urinalysis tests — PSA, CEA, AFP, H. pylori, urine strips
- Lateral flow tests explained — How the test format works
- Product inserts — Instructions for use to download
- Country Station — Rapid test supply by region
- Become a distributor — Distributor application
Request a quote for respiratory tests
Send the products, quantities and destination country. We will confirm availability and documentation for your market.
Regulatory status: Products shown on this website are for professional in vitro diagnostic use. They are not cleared, approved or authorized by the U.S. Food and Drug Administration and are not offered for sale in the United States. Product availability and regulatory status vary by country; contact us for the status in your market.